Literature DB >> 2948368

Neuropeptides in the amygdala of controls, schizophrenics and patients suffering from Huntington's chorea: an immunohistochemical study.

M Zech, G W Roberts, B Bogerts, T J Crow, J M Polak.   

Abstract

The location of the neuropeptides methionine-enkephalin (ME), neurotensin (NT), neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP) within the amygdaloid complex of healthy human individuals, schizophrenics and patients suffering from Huntington's chorea was studied qualitatively by means of immunohistochemistry. VIP-like immunoreactivity (IR) was present predominantly in a dense cluster of fibers and terminals in the central amygdaloid nucleus. ME-IR was observed in fibers, terminals and cell bodies in the same subnucleus, exhibiting a characteristical distribution pattern. NT-positive cell bodies were situated within the center of the central amygdaloid nucleus, fibers and terminals being encountered mainly at the periphery. NPY-IR was found to be evenly distributed throughout the amygdala. Distribution and staining intensity of ME, NPY and NT in the amygdala showed no qualitatively recognizable difference between the normal and schizophrenic specimens, whereas VIP-IR appeared to be slightly increased in the central amygdaloid nucleus of schizophrenics. In the choreic cases, the considerably shrunken amygdala exhibited only very low staining intensity of the four investigated neuropeptides.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2948368     DOI: 10.1007/bf00688048

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  50 in total

1.  Regional and subcellular distributions of brain neurotensin.

Authors:  G R Uhl; S H Snyder
Journal:  Life Sci       Date:  1976-12-15       Impact factor: 5.037

2.  Determination of methionine enkephalin in discrete regions of rat brain.

Authors:  J S Hong; H Y Yang; W Fratta; E Costa
Journal:  Brain Res       Date:  1977-10-07       Impact factor: 3.252

3.  Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease.

Authors:  S H Buck; T F Burks; M R Brown; H I Yamamura
Journal:  Brain Res       Date:  1981-03-30       Impact factor: 3.252

4.  The distribution and ultrastructure of VIP-immunoreactivity in the central nucleus of the rat amygdala.

Authors:  T S Gray; M D Cassell; G Nilaver; E A Zimmerman; T H Williams
Journal:  Neuroscience       Date:  1984-02       Impact factor: 3.590

5.  Ramifications of the globus pallidus in the rat as indicated by patterns of immunohistochemistry.

Authors:  S N Haber; W J Nauta
Journal:  Neuroscience       Date:  1983-06       Impact factor: 3.590

6.  The distribution of enkephalin-immunoreactive cell bodies in the rat central nervous system.

Authors:  T Hökfelt; R Elde; O Johansson; L Terenius; L Stein
Journal:  Neurosci Lett       Date:  1977-06       Impact factor: 3.046

7.  Distribution of pro-opiomelanocortin-derived peptides and enkephalins in the rat central nucleus of the amygdala.

Authors:  T S Gray; M D Cassell; J Z Kiss
Journal:  Brain Res       Date:  1984-07-23       Impact factor: 3.252

8.  The regional distribution of somatostatin, substance P and neurotensin in human brain.

Authors:  P E Cooper; M H Fernstrom; O P Rorstad; S E Leeman; J B Martin
Journal:  Brain Res       Date:  1981-08-10       Impact factor: 3.252

9.  Organization and interrelationship of neuropeptides in the central amygdaloid nucleus of the rat.

Authors:  S Wray; G E Hoffman
Journal:  Peptides       Date:  1983 Jul-Aug       Impact factor: 3.750

10.  [Neuropathology of schizophrenias].

Authors:  B Bogerts
Journal:  Fortschr Neurol Psychiatr       Date:  1984-12       Impact factor: 0.752

View more
  4 in total

1.  Increased density of prohibitin-immunoreactive oligodendrocytes in the dorsolateral prefrontal white matter of subjects with schizophrenia suggests extraneuronal roles for the protein in the disease.

Authors:  Hans-Gert Bernstein; Karl-Heinz Smalla; Diana Dürrschmidt; Gerburg Keilhoff; Henrik Dobrowolny; Johann Steiner; Andrea Schmitt; Michael R Kreutz; Bernhard Bogerts
Journal:  Neuromolecular Med       Date:  2012-06-19       Impact factor: 3.843

Review 2.  Where and what is the paralaminar nucleus? A review on a unique and frequently overlooked area of the primate amygdala.

Authors:  Danielle M deCampo; Julie L Fudge
Journal:  Neurosci Biobehav Rev       Date:  2011-09-01       Impact factor: 8.989

Review 3.  Genetics and neuropathology of Huntington's disease.

Authors:  Anton Reiner; Ioannis Dragatsis; Paula Dietrich
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

4.  Neuropeptides involved in the pathophysiology of schizophrenia and major depression.

Authors:  David De Wied; Hein O. Sigling
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.